Peter Hammerl Selected Research

Peter Hammerl Research Topics

5	Hypersensitivity (Allergy) 06/2017 - 09/2003
3	Neoplasms (Cancer) 01/2020 - 10/2003
2	Necrosis 12/2003 - 03/2002
1	Heart Diseases (Heart Disease) 01/2021
1	Infections 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Idiopathic Pulmonary Fibrosis 01/2021
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2021
1	Disease Progression 01/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Emphysema 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Vascular Diseases (Vascular Disease) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Nausea 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2016
1	Gastritis 01/2016
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2016
1	Lung Diseases (Lung Disease) 12/2011
1	Seasonal Allergic Rhinitis (Hay Fever) 08/2007
1	Eosinophilia 03/2007
1	Anaphylaxis (Anaphylactic Shock) 09/2003
1	Leukemia 09/2002
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2002

5	AllergensIBA 01/2021 - 10/2005
4	DNA (Deoxyribonucleic Acid)IBA 08/2007 - 09/2003
3	Proteins (Proteins, Gene)FDA Link 06/2017 - 10/2005
2	VaccinesIBA 06/2017 - 10/2005
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 06/2017 - 10/2003
2	EpitopesIBA 08/2007 - 10/2003
2	AntibodiesIBA 08/2007 - 09/2003
2	Immunoglobulin E (IgE)IBA 03/2007 - 09/2003
1	CytokinesIBA 01/2021
1	AsbestosIBA 01/2021
1	CollagenIBA 01/2021
1	pirfenidoneIBA 01/2021
1	LigandsIBA 01/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	Peptides (Polypeptides)IBA 06/2017
1	Virulence Factors (Pathogenicity Factors)IBA 01/2016
1	ProstaglandinsIBA 12/2011
1	Endothelin Receptor AntagonistsIBA 12/2011
1	Phosphodiesterase 5 InhibitorsIBA 12/2011
1	ParaffinIBA 03/2007
1	AntigensIBA 03/2007
1	beta-Galactosidase (Lactaid)IBA 03/2007
1	Anti-Allergic Agents (Antiallergic Agents)IBA 03/2007
1	DNA VaccinesIBA 10/2005
1	LipopolysaccharidesIBA 12/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2003
1	Cytotoxins (Cytolysins)IBA 12/2003
1	A-Form DNA (A-DNA)IBA 10/2003
1	Immunoglobulin G (IgG)IBA 09/2003
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 09/2003
1	IonophoresIBA 09/2002
1	Histamine (Histamine Dihydrochloride)FDA Link 09/2002
1	Photosensitizing Agents (Photosensitizers)IBA 03/2002
1	ChloridesIBA 03/2002
1	tetrasulfophthalocyanineIBA 03/2002
1	AluminumIBA 03/2002
1	Caspase 3 (Caspase-3)IBA 03/2002
1	Adenosine Triphosphate (ATP)IBA 03/2002
1	aluminum tetrasulfophthalocyanineIBA 03/2002
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2002

6	Immunotherapy 01/2020 - 10/2003
2	Therapeutics 01/2021 - 06/2017
1	Pneumonectomy (Lung Volume Reduction) 01/2021
1	Photochemotherapy (Photodynamic Therapy) 03/2002